Last update 21 Nov 2024

Fosfluridine tidoxil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fosfluridine
+ [2]
Target
TYMS
Mechanism
TYMS inhibitors(Thymidylate synthase inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Actinic KeratosisBreast CancerColorectal Cancer
Originator Organization
Wilex GmbH Im- u. Export von Investitions- und Verbrauchsgüter
Active Organization-
Inactive Organization
Wilex GmbH Im- u. Export von Investitions- und Verbrauchsgüter
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC34H62FN2O10PS
InChIKeyLBBDGLOPGRGFDO-FKJRLRTPSA-N
CAS Registry174638-15-4

Related

2
Clinical Trials associated with Fosfluridine tidoxil
EUCTR2005-001680-57-AT / Not yet recruitingNot Applicable
Phase II study of fosfluridine tidoxil in an oral multiple dose schedule given once-a-day for 7 consecutive days every 2 weeks in patients with advanced breast and colorectal cancer
EUCTR2005-000394-21-DE / Not yet recruitingNot Applicable
A Double-Blind Phase II Study of HDP 99.0006 in Patients with Actinic Keratosis - A Double-Blind Phase II Study of HDP 99.0006 in Patients with Actinic Keratosis
100 Clinical Results associated with Fosfluridine tidoxil
Login to view more data
100 Translational Medicine associated with Fosfluridine tidoxil
Login to view more data
100 Patents (Medical) associated with Fosfluridine tidoxil
Login to view more data
100 Deals associated with Fosfluridine tidoxil
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Actinic KeratosisPhase 2-
Wilex GmbH Im- u. Export von Investitions- und Verbrauchsgüter
-
Breast CancerPhase 2-
Wilex GmbH Im- u. Export von Investitions- und Verbrauchsgüter
-
Colorectal CancerPhase 1-
Wilex GmbH Im- u. Export von Investitions- und Verbrauchsgüter
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free